Skip to main content

Laura Costa Comellas

Institutions of which they are part

Predoctoral researcher
Pediatric Neurology
Vall Hebron Institut de Recerca

Laura Costa Comellas

Institutions of which they are part

Predoctoral researcher
Pediatric Neurology
Vall Hebron Institut de Recerca

Projects

RED ESPAÑOLA DE NEUROPATÍAS AUTOINMUNES - Spanish Partnership for Autoimmune Neuropathies (SPAiN)

IP: Arnau Llauradó Gayete
Collaborators: Josep Quer Sivila, Laura Costa Comellas
Funding agency: Instituto de Salud Carlos III
Funding: 480370
Reference: PMPER24/00018
Duration: 01/01/2025 - 31/12/2026

Distrofia muscular congénita tipo 1A: inhibición de la fibrosis y corrección mediante edición génica

IP: Jordi Barquinero Mañez
Collaborators: Laura Costa Comellas, Francina Munell Casadesus, David Gómez Andrés, Rocío Piñera Moreno, Maria Pallares Masmitja
Funding agency: Instituto de Salud Carlos III
Funding: 117370
Reference: PI22/01027
Duration: 01/01/2023 - 31/12/2025

Neurologia infantil

IP: Alfons Macaya Ruíz
Collaborators: Laia Ventura i Expósito, Belen Perez Dueñas, Laura Costa Comellas, Francina Munell Casadesus, Anna Marcé Grau, Miquel Raspall Chaure, Mireia Del Toro Riera, Julia Sala Coromina, Ana Felipe Rucián, Ana Laura Cazurro Gutierrez, David Gómez Andrés, Amaia Lasa Aranzasti, Lucy Dougherty de Miguel
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 01171
Duration: 01/01/2022 - 30/06/2025

Mejora del rendimiento diagnóstico en genes sarcoméricos de gran tamaño

IP: Francina Munell Casadesus
Collaborators: Laura Costa Comellas, Elena Antima Martinez Saez, Maite Avilés García, David Gómez Andrés
Funding agency: Instituto de Salud Carlos III
Funding: 73205
Reference: AC19/00048
Duration: 01/01/2020 - 31/12/2023

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

Related professionals

Anas Chaachou Charradi

Anas Chaachou Charradi

Predoctoral researcher
Translational Molecular Pathology
Read more
Ana Maria Ciscar Bellés

Ana Maria Ciscar Bellés

Postdoctoral researcher
General Surgery
Read more
Guillem Puigsech Boixeda

Guillem Puigsech Boixeda

Predoctoral researcher
Microbiology
Read more
Sara Martin Sastre

Sara Martin Sastre

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.